Baird Maintains Neutral on HCA Healthcare, Lowers Price Target to $393
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice TargetHot
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $396 to $393.
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $396 to $393.